Maxim Group Upgrades Titan Pharmaceuticals (TTNP) to Buy

October 23, 2019 7:44 AM EDT Send to a Friend
Maxim Group analyst Jason McCarthy upgraded Titan Pharmaceuticals (NASDAQ: TTNP) from Hold to Buy with a price target of $1.00.We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login